Connection

Miguel Abboud to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications Miguel Abboud has written about Clinical Trials, Phase III as Topic.
Miguel Abboud
Connection Strength
0.041
Clinical Trials, Phase III as Topic
  1. Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3). Contemp Clin Trials. 2019 10; 85:105835.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.